Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium

Por Zhang, Lifang, Wang, Dan, Jiang, Wei, Edwards, Dale, Qiu, Weiliang, Barroilhet, Lisa M, Rho, Jung-hyun, Jin, Lianjin, Seethappan, Vanitha, Vitonis, Allison, Wang, Jianliu, Mok, Samuel C, Crum, Christopher, Cramer, Daniel W, Ye, Bin
Publicado em 2010

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

Por Konstantinopoulos, Panagiotis A, Cheng, Su-Chun, Hendrickson, Andrea E Wahner, Penson, Richard T, Schumer, Susan T, Doyle, L Austin, Lee, Elizabeth K, Kohn, Elise C, Duska, Linda R, Crispens, Marta A, Olawaiye, Alexander B, Winer, Ira S, Barroilhet, Lisa M, Fu, Siqing, McHale, Michael T, Schilder, Russell J, Färkkilä, Anniina, Chowdhury, Dipanjan, Curtis, Jennifer, Quinn, Roxanne S, Bowes, Brittany, D’Andrea, Alan D, Shapiro, Geoffrey I, Matulonis, Ursula A
Publicado no Lancet Oncol (2020)